Clinical Trial Update: Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting discontinuation of TNF-alpha inhibitors in patients with spondyloarthritis and terminated status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondyloarthritis

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: SPONDYLOARTHRITIS | Phase 4 | Status: TERMINATED